Research Studies
SMA 07 08: Glaucoma Study, phase 3
Assessing the efficacy of a combination of currently approved glaucoma
drugs for the treatment of elevated eye pressures.
Open Enrollment
Contact: Deb Battin
970 221-2222 x 240
or
C 07 35: New glaucoma treatment
Enrollment will start in May or June
Contact: Deb Battin
970 221-2222 x 240
or
C 05 04: Corneal Infiltrate Study, phase 3
Assessing the efficacy of a new drug on the treatment Of Corneal
Infiltrates.
Open Enrollment
Contact: Deb Battin
970 221-2222 x 240
or
|